Literature DB >> 730188

Nasopharyngeal carcinoma in children and adolescents in Tunisia: clinical aspects and the paraneoplastic syndrome.

R Ellouz, M Cammoun, R B Attia, J Bahi.   

Abstract

Of 485 cases of NPC collected from the files of our institute between March 1969 and December 1974, 82 (17%) were in children and adolescents (0--19 years old). This relatively high frequency of NPC in young people was not suggested by reports from high-incidence areas (Southern China, for example) but appears to be a characteristic feature of areas of intermediate incidence (Uganda, Kenya, Sudan, Tunisia). NPC is the tumour that occurs most frequently in young people between 1 and 20 years old in Tunisia, showing a peak in those 16 years of age. The male:female sex ratio was 3:1. Advanced stages of the disease occured frequently; no clinical anomalies were noted in this age group. The 'nasopharyngeal' type of carcinoma was the histological form seen most frequently; poorly-differentiated squamous-cell carcinomas were not uncommon; and well-differentiated squamous-cell carcinomas were not seen in this series. The five-year survival rate was 32.5% for children and only 20% for adults. This can perhaps be explained by the fact that the 'nasopharyngeal' type of tumour has a better prognosis than other histological types, and, compared to adults, younger patients more frequently have distant metastases (37%) than local recurrences (18.5%). A paraneoplastic syndrome, consisting of hypertrophic pulmonary osteoarthropathy with occasional generalized lowering of pituitary function, was seen in 12 of the patients. This syndrome has been described only in children, and no cases were found in our series of adult NPC patients. Epidemiological, clinical and histological aspects suggest that NPC in young people is different from that found in adults.

Entities:  

Mesh:

Year:  1978        PMID: 730188

Source DB:  PubMed          Journal:  IARC Sci Publ


  7 in total

Review 1.  Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.

Authors:  T Ooka; M de Turenne-Tessier; M C Stolzenberg
Journal:  Springer Semin Immunopathol       Date:  1991

2.  Challenges of managing nasopharyngeal carcinoma in a developing country.

Authors:  Olawunmi Fatusi; Olubunmi Akinpelu; Yemisi Amusa
Journal:  J Natl Med Assoc       Date:  2006-05       Impact factor: 1.798

3.  The incidence of Epstein-Barr virus in nasopharyngeal carcinoma of Jordanian patients.

Authors:  Ismail Matalka; Mohammad Al Hamad; Maysa Al-Hussaini; Firas Q Alzoubi
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-16       Impact factor: 2.503

Review 4.  Screening for nasopharyngeal cancer.

Authors:  Shujuan Yang; Siying Wu; Jing Zhou; Xiao Y Chen
Journal:  Cochrane Database Syst Rev       Date:  2015-11-06

Review 5.  Nasopharyngeal carcinoma.

Authors:  Bernadette Brennan
Journal:  Orphanet J Rare Dis       Date:  2006-06-26       Impact factor: 4.123

6.  CD4-positive lymphoepithelial-like carcinoma: Report of unusual case.

Authors:  Luaay Aziz; Raya Saab; Toufic Eid; Mousa A Al-Abbadi
Journal:  Avicenna J Med       Date:  2018 Apr-Jun

7.  Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay.

Authors:  Imran Nawaz; Khalid Moumad; Debora Martorelli; Moulay Mustapha Ennaji; Xiaoying Zhou; Zhe Zhang; Riccardo Dolcetti; Meriem Khyatti; Ingemar Ernberg; Li-Fu Hu
Journal:  Clin Epigenetics       Date:  2015-08-22       Impact factor: 6.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.